Israel's BOL Pharma Aims for Top of the World's Medical Marijuana Industry

The company will sell shares in Toronto expected to value it at around $1 billion

Shelly Appelberg
Shelly Appelberg
Send in e-mailSend in e-mail
Tamir Gedo, the CEO of the medical marijuana company BOL Pharma.
Tamir Gedo, the CEO of the medical marijuana company BOL Pharma.Credit: Eyal Toueg

Comments